Cadrenal Therapeutics Inc. (NASDAQ: CVKD) Stock Information | RedChip

Cadrenal Therapeutics Inc. (NASDAQ: CVKD)


$14.7300
-1.4400 ( -8.00% ) 30.9K

Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.

Market Data


Open


$14.7300

Previous close


$16.1700

Volume


30.9K

Market cap


$24.14M

Day range


$13.4720 - $16.6100

52 week range


$5.4000 - $32.5500

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 58 Nov 07, 2024
8-k 8K-related 14 Nov 07, 2024
8-k 8K-related 17 Nov 04, 2024
8-k 8K-related 14 Oct 24, 2024
8-k 8K-related 48 Sep 25, 2024
8-k 8K-related 13 Sep 05, 2024
8-k 8K-related 14 Aug 20, 2024
8-k 8K-related 14 Aug 16, 2024
8-k 8K-related 14 Aug 08, 2024
10-q Quarterly Reports 60 Aug 07, 2024

Latest News